UL Solution For 2024 Anticipates Mid-To-High Single-Digit Organic Revenue Growth, Improved Adjusted EBITDA Margin And Capital Expenditures At 8.0-8.5% Of Revenue

Benzinga
2024-11-05

Full-Year 2024 Outlook

The Company's key points on 2024 outlook include:

  • Increasing to mid-to-high single digit constant currency, organic revenue growth
  • Q4 constant currency, organic revenue growth expected to be in the mid-to-high single digit range
  • Reiterating full-year Adjusted EBITDA margin improvement
  • Capital expenditures expected to be 8.0 to 8.5% of revenue
  • Continuing to pursue acquisitions and portfolio refinements

The Company's 2024 outlook is based on a number of assumptions that are subject to change and many of which are outside the control of the Company. If actual results vary from these assumptions, the Company's expectations may change. There can be no assurance that the Company will achieve the results expressed by this outlook.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10